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fact that the risk of morbidity and mortality can be too high. 
For these patients unfit for surgery, definitive radiotherapy is 
an option that should seriously be considered. This, however, 
requires a higher dose on the primary tumour, to increase the 
likelihood of complete response. In this respect, 
brachytherapy (BT) is an appealing treatment modality.  In 
comparison to external beam radiotherapy, it offers the 
advantage of delivering a high dose of radiation with a rapid 
dose fall-off around the site of interest (tumour target).  
From published studies it is clear that for relatively small 
tumours, local treatment with either contact X-rays or 
intraluminal brachytherapy is a reasonable option. For 
patients with larger tumours, the risk of nodal involvement 
makes the combination of local radiotherapy with external 
beam radiotherapy necessary.  
So far, this combination has mainly been given with contact 
X-rays and only sporadically with intraluminal brachytherapy. 
In this presentation, a summary of published studies will be 
given, with an update on the HERBERT trial, a brachytherapy 
trial for medically unfit patients with T2-T4 rectal tumours. 
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Prostate cancer is a major health issue in aging men. No 
treatment is required in less aggressive prostate cancer but 
there is consensus that radical treatment is needed in 
aggressive prostate cancer. Radical treatment has to start 
while the tumor is still confined to the gland and has not 
spread beyond. Potential side effects of radical treatment, 
such as impotence and incontinence, have a substantial 
impact on quality of life. This is of special importance 
because more than 25% of patients eligible for radical 
treatment are in the age range of 40 to 65 years. 
Conventional anatomical T2-weighted MR imaging is the 
mainstay in prostate cancer imaging. On T2-weighted MR 
images, normal prostate tissue displays an intermediate to 
high signal intensity while the central gland has lower signal 
intensity than the peripheral zone. Currently several new MR 
imaging techniques are being explored. These include: 1H-MR 
spectroscopic imaging (MRSI), dynamic contrast-enhanced MR 
imaging (DCE-MRI), and diffusion weighted imaging (DWI).  
MRSI is a unique method that can provide information based 
on tumor metabolism. The chemical environment of protons 
within a certain molecule defines their so-called chemical 
shift: a unique resonance frequency when positioned in a 
magnetic field, which can be observed in an MR spectrum. 
Specific spectral profiles reflect the identity of (bio-) 
chemicals present at that location and the intensity of the 
spectral signals is related to the tissue levels of these 
compounds. Analytical and clinical studies have shown 
significant differences of the metabolic state of the different 
tissue types by MRSI. 
Dynamic contrast-enhanced MR imaging – with a low 
molecular weight contrast media (<1 kDa) enables non-
invasive imaging of tumor angiogenesis. DCE-MRI is the most 
common imaging method for evaluating human tumor 
vascular function in situ. Insights into these physiologic 
processes are obtained qualitatively by characterizing kinetic 
enhancement curves or quantitatively by applying complex 
compartmental modeling techniques. Data reflecting the 
tissue perfusion (blood flow, blood volume, and mean transit 
time), the microvessel permeability, and the extracellular 
leakage space can be obtained. 
Diffusion weighted MR imaging – can quantify the water 
motion in an indirect manner. The DWI pulse sequence labels 
hydrogen nuclei in space, of which most will be part of water 
molecules at any moment, and determines the length of the 
path that water molecules travel over a short period of time. 
DWI is able to estimate the mean distance traveled by all 
hydrogen nuclei in every voxel of imaged tissue. The greater 
this mean distance the more self-diffusion of water 
molecules has taken place in a certain time interva . From 
this estimate an apparent diffusion coefficient (ADC) as a 
reflection of the self-diffusion of water in tissue in a certain 
direction can be calculated. 
Multiple studies have explored optimal parameter settings for 
the diagnostic MR-protocol, which allows accurate tumor 
localization and tumor volume assessment. Although reported 
accuracies of the different separate and combined 
multiparametric MR imaging techniques vary for diverse 
clinical prostate cancer indications, multiparametric prostate 
MR imaging has shown promising results and may be of 
additional value in prostate cancer localization and local 
staging. To increase MR imaging accuracy for the different 
clinical prostate cancer indications, one or more functional 
MR imaging techniques should be combined with T2-weighted 
MR imaging in a multiparametric MR imaging exam of the 
prostate. 
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High dose rate (HDR) brachytherapy can deliver a high, 
localised radiation dose to the prostate which results in 
excellent biochemical control of prostate cancer. Multi-
parametric magnetic resonance imaging (mpMRI) can be used 
to define regions within the prostate that are at highest risk 
of containing clinically significant tumour. Incorporation of 
these multi-parametric datasets into the HDR brachytherapy 
planning process facilitates ‘dose painting’ where regions of 
greatest risk are given a higher radiotherapy dose using an 
inhomogeneous plan (figure). 
 
 
Figure: HDR brachytherapy with focussed dose escalation. A 
dominant intra-prostatic lesion (DIL) in the right postero-
lateral peripheral zone has been defined using multi-
parametric MRI. High dose rate brachytherapy catheters 
have been inserted under general anaesthetic. The planning 
computer optimisation software has been programmed to 
maximise the radiation dose to the DIL and limit the dose to 
the rest of the prostate to a defined ceiling.  
